Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results
Appointed director

Aevi Genomic Medicine, Inc. (CERC) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/03/2020 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs: "Certificate of Formation of Second Genie Merger Sub, LLC",
"Limited Liability Company Agreement of Second Genie Merger Sub, LLC",
"Option Termination Agreement, effective February 3, 2020, by and between Aevi Genomic Medicine, Inc. and Michael F. Cola",
"Option Termination Agreement, effective February 3, 2020, by and between Aevi Genomic Medicine, Inc. and Garry A. Neil"
12/23/2019 8-K Quarterly results
12/10/2019 8-K/A Acquisition/merger/asset purchase announced
Docs: "Agreement and Plan of Merger and Reorganization, among Aevi Genomic Medicine, Inc., Genie Merger Sub, Inc., Second Genie Merger Sub, LLC and Cerecor Inc. (including the Form of Contingent Value Rights Agreement)"
12/05/2019 8-K Acquisition/merger/asset purchase announced
Docs: "Agreement and Plan of Merger and Reorganization, among Aevi Genomic Medicine, Inc., Genie Merger Sub, Inc., Second Genie Merger Sub, LLC and Cerecor Inc. (including the Form of Contingent Value Rights Agreement)",
"Form of Voting Agreement of Aevi Genomic Medicine, Inc.",
"Promissory Note for License Expenses, by and between Cerecor Inc. and Aevi Genomic Medicine, Inc",
"Promissory Note for Operating Expenses, by and between Cerecor Inc. and Aevi Genomic Medicine, Inc",
"Cerecor to Acquire Aevi Genomic Medicine"
11/22/2019 8-K Other Events
11/20/2019 8-K Entry into a Material Definitive Agreement
10/15/2019 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial ...
Docs: "Aevi Genomic Medicine, Inc. Receives Positive Nasdaq Listing Determination"
10/04/2019 8-K Entry into a Material Definitive Agreement
09/10/2019 8-K Submission of Matters to a Vote of Security Holders
08/09/2019 8-K Quarterly results
08/07/2019 8-K Investor presentation
Docs: "Aevi Genomic Medicine Enters into License Agreement with AstraZeneca for Anti-IL-18 Antibody",
"Investor Presentation – August 2019"
07/19/2019 8-K Entry into a Material Definitive Agreement
07/15/2019 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Aevi Genomic Medicine Enters into Worldwide License Agreement with Astellas to Develop and Commercialize a Novel Second Generation mTORC1/2 Inhibitor"
06/24/2019 8-K Quarterly results
05/21/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Letter Agreement, by and between Aevi Genomic Medicine, Inc. and Michael McInaw"
04/08/2019 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
02/12/2019 8-K Quarterly results
01/02/2019 8-K Other Events, Financial Statements and Exhibits
Docs: "Aevi Genomic Medicine Announces Top-Line Results from Placebo-Controlled ASCEND Trial of AEVI-001 in Children with ADHD"
08/14/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "Aevi Genomic Medicine Announces Completion of Enrollment in Part A of Phase 2 ASCEND Trial in ADHD"
06/22/2018 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
06/20/2018 8-K Submission of Matters to a Vote of Security Holders
03/21/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/13/2018 8-K Quarterly results
Docs: "Aevi Genomic Medicine Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update",
"Presentation Deck"
03/06/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/04/2017 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Form of Indemnification Agreement",
"Aevi Genomic Medicine Announces New Appointment to its Board of Directors"
10/18/2017 8-K Quarterly results
08/15/2017 8-K Quarterly results
08/11/2017 8-K Quarterly results
08/10/2017 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Aevi Genomic Medicine Announces Agreement for $28 Million Private Placement PHILADELPHIA, PA – – 08/10/17",
"Slide Presentation"
08/09/2017 8-K Quarterly results
Docs: "Aevi Genomic Medicine Reports Second Quarter 2017 Financial Results"
06/30/2017 8-K Other Events
06/19/2017 8-K Form 8-K - Current report
05/10/2017 8-K Form 8-K - Current report
04/25/2017 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy